In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Associate Professor Marek Jastrzebski
Speaker
Associate Professor Marek Jastrzebski
Marek Jastrzebski Marek Jastrzebski

University Hospital, 1st Department of Cardiology and Hypertension, Krakow (Poland)

Speciality : Arrhythmias-General

Prof. Jastrzebski, MD, PhD graduated from the Jagiellonian University in Kraków, Poland, in 1995 and works in the 1st. Dep. of Cardiology and Interventional Electrocardiology UJ. After short stays in several centers in Europe and USA, he introduced new treatment options in his EP lab: ICDs, RF ablations, 3D abl, fluoroless abl, CRT, cardiac venoplasty, cryoballoons etc. He performed over 6000 EP procedures including > 800 WPW abl., > 500 cryoballoons, > 500 CRTs and > 300 His bundle implants. As the first electrophysiologist in Poland he obtained both EHRA certificates (“Clinical Cardiac Pacing” 2006, “Invasive Electrophysiology” 2007) and both Polish Cardiac Society certificates: "Expert in Electrophysiology", "Expert in Electrotherapy". Prof. Jastrzebski published > 180 papers and especially values his CRT research (“delta QRS” ,”LV QRS”, etc.), the “VT score method” for diagnosis of wide QRS complex tachycardias, and the introduction of the “Programmed His bundle pacing” maneuver.

1 presentation from this speaker

His-Purkinje system pacing in single centre experience after 324 cases

Event : ESC Congress 2019

  • Session : Is his bundle pacing the new answer ?
  • Speaker : M Jastrzebski (Krakow,PL)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are